Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19

dc.contributor.authorKakurina, Natalja
dc.contributor.authorKadisa, Anda
dc.contributor.authorLejnieks, Aivars
dc.contributor.authorMikazane, Helena
dc.contributor.authorKozireva, Svetlana
dc.contributor.authorMurovska, Modra
dc.contributor.institutionDepartment of Internal Diseases
dc.contributor.institutionInstitute of Microbiology and Virology
dc.date.accessioned2021-05-28T11:15:01Z
dc.date.available2021-05-28T11:15:01Z
dc.date.issued2015
dc.descriptionFunding Information: This study was supported in part by the grant 09.1112 of the Latvian Council of Sciences and National Program in Biomedicine (2009–2013). Publisher Copyright: © 2015 Lithuanian University of Health Sciences. Copyright: Copyright 2016 Elsevier B.V., All rights reserved.
dc.description.abstractBackground and objective: We evaluated a possible correlation between the clinical activities of rheumatoid arthritis (RA) and human parvovirus B19 (B19) infection using exploratory factor analysis (EFA). Materials and methods: RA patients were organized into two groups: 100 patients in the main group and 97 in the RA(DAS28) group. Four subgroups were defined from the main group according to the presence or absence of certain infection-specific markers: group I comprised 43 patients who had IgG antibodies against B19; group II, 25 patients with active B19 infection (B19-specific IgM antibodies and/or plasma viremia); group III, 19 patients with latent/persistent B19 infection (virus-specific sequences in peripheral blood leukocytes' DNA with or without B19-specific IgG antibodies), and group IV, 13 patients without infection markers. The RA(DAS28) group was divided into four subgroups similarly to the main group: group I, 35; group II, 31; group III, 19; and group IV, 12 patients. Disease-specific clinical values in both groups were analyzed employing EFA, and the RA(DAS28) group was additionally assessed using Disease Activity Score (DAS)28. Results: RA activity was higher in patients who had markers of B19 infection. The highest activity of RA in both study groups was in patients with latent/persistent infection. In the RA(DAS28) group, according to DAS28, the highest activity of RA was in patients with active B19 infection. Conclusions: Using EFA and DAS28, a correlation between the clinical activity of RA and B19 infection was confirmed. These data suggest that EFA is applicable for medico-biological studies.en
dc.description.statusPeer reviewed
dc.format.extent7
dc.format.extent1026086
dc.identifier.citationKakurina, N, Kadisa, A, Lejnieks, A, Mikazane, H, Kozireva, S & Murovska, M 2015, 'Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19', Medicina (Lithuania), vol. 51, no. 1, pp. 18-24. https://doi.org/10.1016/j.medici.2015.01.004
dc.identifier.doi10.1016/j.medici.2015.01.004
dc.identifier.issn1010-660X
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/4563
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=84951977658&partnerID=8YFLogxK
dc.language.isoeng
dc.relation.ispartofMedicina (Lithuania)
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectExploratory factor analysis
dc.subjectHuman parvovirus B19
dc.subjectRheumatoid arthritis
dc.subject3.2 Clinical medicine
dc.subject1.6 Biological sciences
dc.subject3.1 Basic medicine
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database
dc.subjectGeneral Medicine
dc.subjectSDG 3 - Good Health and Well-being
dc.titleUse of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19en
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Use_of_exploratory_factor_analysis.pdf
Size:
1002.04 KB
Format:
Adobe Portable Document Format